PCN230 - ARE NICE AND THE SMC DIVERGING IN THEIR ASSESSMENT OF ONCOLOGY DRUGS?
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.312
https://www.valueinhealthjournal.com/article/S1098-3015(18)33612-X/fulltext
Title :
PCN230 - ARE NICE AND THE SMC DIVERGING IN THEIR ASSESSMENT OF ONCOLOGY DRUGS?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33612-X&doi=10.1016/j.jval.2018.09.312
First page :
Section Title :
Open access? :
No
Section Order :
2217